OMB APPROVAL
OMB Number: 3235-0006
Expires: August 31, 2012
Estimated average burden
hours per response..........22.6

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 13F

FORM 13F COVER PAGE

Report for the Calendar Year or Quarter Ended: December 31, 2011

Check here if Amendment [ ]; Amendment Number:

This Amendment (Check only one.): [ ] is a restatement.

[ ] adds new holdings entries.

Institutional Investment Manager Filing this Report: 

Name: Consonance Capital
Address: 888 Seventh Avenue, 43rd Floor
 New York, New York 10019

Form 13F File Number:

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.

Person Signing this Report on Behalf of Reporting Manager: 

Name: Kevin H. Livingston
Title: Managing Director
Phone: 212-660-8060

Signature, Place, and Date of Signing: 

/s/ Kevin H. Livingston New York, New York March 15, 2012
----------------------- ------------------- ------------------
 [Signature] [City, State] [Date]

Report Type (Check only one.):

[X] 13F HOLDINGS REPORT.(Check here if all holdings of this reporting manager
are reported in this report.)

[ ] 13F NOTICE. (Check here if no holdings reported are in this report, and
all holdings are reported by other reporting manager(s).)

[ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).) 

 Form 13F Summary Page

Report Summary:

Number of Other Included Managers: 0
 -------

Form 13F Information Table Entry Total: 15
 -------

Form 13F Information Table Value Total: $92,584
 -------
 (thousands)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.

No. Form 13F File Number Name 
 Consonance Capital
 Form 13F Information Table
 Quarter ended December 31, 2011


 COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
 VALUE SHRS or SH/ PUT/ INVE OTH VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISC MAN SOLE SHARED NONE
---------------------------- -------------- --------- --------- --------- --- ---- ---- --- --------- ------ ----
ABAXIS INC COM 002567105 $ 3,154 114,000 SH SOLE 114,000
BIOSCRIP INC COM 09069N108 $ 6,427 1,177,061 SH SOLE 1,177,061
COMPUTER PROGRAMS & SYS INC COM 205306103 $ 5,841 114,274 SH SOLE 114,274
DERMA SCIENCES INC COM PAR $.01 249827502 $ 305 40,216 SH SOLE 40,216
EXPRESS SCRIPTS INC COM 302182100 $ 9,590 214,600 SH SOLE 214,600
JAZZ PHARMACEUTICALS INC COM 472147107 $ 15,977 413,600 SH SOLE 413,600
MEDCATH CORP COM 58404W109 $ 816 111,957 SH SOLE 111,957
MEDICINES CO COM 584688105 $ 4,235 227,200 SH SOLE 227,200
NATUS MEDICAL INC DEL COM 639050103 $ 3,983 422,422 SH SOLE 422,422
OPTIMER PHARMACEUTICALS INC COM 68401H104 $ 4,479 365,946 SH SOLE 365,946
QUESTCOR PHARMACEUTICALS INC COM 74835Y101 $ 15,798 379,952 SH SOLE 379,952
SAGENT PHARMACEUTICALS INC COM 786692103 $ 6,057 288,449 SH SOLE 288,449
SANTARUS INC COM 802817304 $ 6,939 2,096,370 SH SOLE 2,096,370
SHANGPHARMA CORP SPONSORED ADR 81943P104 $ 3,749 515,701 SH SOLE 515,701
WUXI PHARMATECH CAYMAN INC SPONS ADR SHS 929352102 $ 5,234 474,100 SH SOLE 474,100

Total Fair Market Value (in thousands): $ 92,584